ALSO NOTED: Ranbaxy gets approval; FDA warns nursing mothers on codeine;

> Ranbaxy Pharmaceuticals got the FDA thumbs-up on its generic version of the hydrocodone-and-acetaminophen combo marketed by others as Vicodin and Lorcet, among other names. Total 2006 sales for the combination pills was $390.6 million. Release

> The FDA is warning nursing mothers who take the painkiller codeine to watch for signs of overdose--such as excess drowsiness--in their babies. Up to 10 percent of white women and 3 percent of black women have a particular gene that concentrates narcotics into their breast milk. Report

> Bayer Healthcare Pharmaceuticals and Onyx Pharmaceuticals got their liver cancer treatment Nexavar onto the FDA fast track. The agency has accepted the companies' app for Priority Review. The drug already is approved for use against kidney cancer. Release

> China Shenghuo Pharmaceutical Holdings posted a 29.3 percent increase in second-quarter profits, to $1.3 million, on sales of $6.4 million. Report

And Finally... A new frontier in diabetes treatment could be a big boon not only for patients, but also for drug makers who supply statins and other heart-related remedies. Article

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.